Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Ascending Dose Study of MT-3534 in Healthy Adult Male Volunteers
jRCT2031240187Phase 1Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Aug 2024
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing MT-3534 IV with Placebo IV (2 arms). Primary endpoints: Number of subjects with adverse events, Number of subjects with adverse reactions and 1 more. Started Aug 2024; status: completed.
02
Drugs
MT-3534
Beyond the preview
Go deeper on jRCT2031240187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240187.